COST-EFFECTIVENESS ANALYSIS OF RHBMP-2 IN THE TREATMENT OF OPEN TIBIA FRACTURES IN THE NETHERLANDS

被引：0
|
作者：
Van Genugten, M. [1 ]
Chhabra, A. [2 ]
Alt, V [3 ]
机构：
[1] Medtron Trading NL BV, Heerlen, Netherlands
[2] Medtron Europe SA, Tolochenaz, Switzerland
[3] Univ Hosp Giessen Marburg, Brackenheim, Germany
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)66795-2
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A544 / A544
页数：1
相关论文
共 50 条
  • [31] RETROSPECTIVE ANALYSIS OF EFFECTIVENESS OF DIFFERENT FLAPS IN PATIENTS WITH OPEN TIBIA FRACTURES
    Shibaev, E. Yu.
    Vlasov, A. P.
    Kisel, D. A.
    Lazarev, M. P.
    Nevedrov, A. V.
    Tsoglin, L. L.
    Ivanov, P. A.
    TRAVMATOLOGIYA I ORTOPEDIYA ROSSII, 2013, (03): : 5 - 12
  • [32] Cost-effectiveness analysis of treatments for vertebral compression fractures
    Edidin A.A.
    Ong K.L.
    Lau E.
    Schmier J.K.
    Kemner J.E.
    Kurtz S.M.
    Applied Health Economics and Health Policy, 2012, 10 (4) : 273 - 284
  • [33] Diagnosis of Occult Scaphoid Fractures A Cost-Effectiveness Analysis
    Karl, John W.
    Swart, Eric
    Strauch, Robert J.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2015, 97A (22): : 1860 - 1868
  • [34] Prevention of osteoporosis - A cost-effectiveness analysis regarding fractures
    Norlund, A
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1996, : 42 - 45
  • [35] the Bone Healing with Growth Factors to accelerate Good Data for rhBMP-2 in open Tibial Fractures and ALIF
    Schmidmaier, G.
    Wildemann, B.
    Zimmermann, G.
    Rauschmann, M.
    Wagner, F.
    Alt, V.
    Scheufler, K. -M.
    ZEITSCHRIFT FUR ORTHOPADIE UND UNFALLCHIRURGIE, 2012, 150 (01): : B4 - B11
  • [36] COST-EFFECTIVENESS ANALYSIS OF ANTIEMETIC TREATMENT
    BLEIBERG, H
    AUTIER, P
    MICHAUX, D
    SUPPORTIVE CARE IN CANCER, 1994, 2 (03) : 145 - 149
  • [37] TREATMENT OF OPEN FRACTURES OF TIBIA AND ANKLE
    OLERUD, S
    KARLSTROM, G
    DANCKWARDTLILLIESTROM, G
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1978, (136) : 212 - 224
  • [38] Cost-effectiveness model of Palivizumab in The Netherlands
    Nuijten, MJ
    Lebmeier, M
    Daalderop, P
    Wittenberg, W
    VALUE IN HEALTH, 2005, 8 (06) : A52 - A52
  • [39] Cost-effectiveness of statin therapy in The Netherlands
    Goes, ES
    VanHout, BA
    AMERICAN JOURNAL OF MANAGED CARE, 1997, 3 (10): : LC3 - LC3
  • [40] Cost-effectiveness of rotavirus vaccination in the Netherlands
    Welte, R
    Jager, JC
    Van Duynhoven, Y
    De Wit, M
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1228 - 1228
12345